Controversial cancer drug wins local approval in Italy.
Abbott
A
A
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D007558:Italy; D013004:Somatostatin / Q000191:economics / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013004:Somatostatin